We support the C17 Council, a national organization of childhood cancer and blood disease experts in Canada. C17 is dedicated to childhood cancer initiatives, and actively advocates for policies that improve outcomes and quality of life for children.
Since 2004, we’ve been the primary charitable funding partner for the C17 Council, supporting clinical trials and childhood cancer research in Canada.
The C17 Council is led by the hematology and oncology division directors from all of the Canadian centres that treat children with cancer, including Canada’s leading pediatric institutions, oncologists, and hematologists. We work with the C17 Council to increase survival rates and improve wellbeing for children with the ultimate goal of finding a cure for all childhood cancers.
This research includes discovering new targeted drug approaches, starting clinical trials to move new discoveries to patient treatment, improving the success of bone marrow transplants, and mitigating the long-term effects of cancer treatments.
We help raise funds for the C17 Council to increase resources that drive paediatric oncology research and develop larger impact studies — increasing the number of clinical trials and powering research forward to clinical application.
“Over 80% of children with cancer can now have a cure. However, many of these children will have serious health issues later in life. New treatments such as immunotherapy and precision cancer medicine offer the hope of more cures with fewer serious side effects.”
—Dr. Jim Whitlock, Pediatric Oncologist, Chair of C17 Council, Co-Lead of the PROFYLE Therapeutics Node, Head Haematology/Oncology at The Hospital for Sick Children, Board of Directors, Childhood Cancer Canada
Lorem ipsum dolor sit amet consectetur. Fusce a elit non vulputate. In nunc in lacus pretium aliquam in vel. Consectetur velit convallis enim egestas in nulla etiam eget. Id ut etiam morbi vulputate. Feugiat lobortis arcu facilisi porttitor. Sem enim ornare lacus non mauris eget fusce euismod rutrum congue.
Lorem ipsum dolor sit amet consectetur. Fusce a elit non vulputate. In nunc in lacus pretium aliquam in vel. Consectetur velit convallis enim egestas in nulla etiam eget. Id ut etiam morbi vulputate. Feugiat lobortis arcu facilisi porttitor. Sem enim ornare lacus non mauris eget fusce euismod rutrum congue.
Lorem ipsum dolor sit amet consectetur. Fusce a elit non vulputate. In nunc in lacus pretium aliquam in vel. Consectetur velit convallis enim egestas in nulla etiam eget. Id ut etiam morbi vulputate. Feugiat lobortis arcu facilisi porttitor. Sem enim ornare lacus non mauris eget fusce euismod rutrum congue.
Lorem ipsum dolor sit amet consectetur. Fusce a elit non vulputate. In nunc in lacus pretium aliquam in vel. Consectetur velit convallis enim egestas in nulla etiam eget. Id ut etiam morbi vulputate. Feugiat lobortis arcu facilisi porttitor. Sem enim ornare lacus non mauris eget fusce euismod rutrum congue.
